198 related articles for article (PubMed ID: 30566308)
1. Cell-based therapies for Parkinson's disease.
Sakaguchi H; Takahashi J
Nihon Rinsho; 2017 Jan; 75(1):141-145. PubMed ID: 30566308
[TBL] [Abstract][Full Text] [Related]
2. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
[TBL] [Abstract][Full Text] [Related]
3. Induced dopaminergic neurons: A new promise for Parkinson's disease.
Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
[TBL] [Abstract][Full Text] [Related]
4. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
[TBL] [Abstract][Full Text] [Related]
5. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
Fan Y; Winanto ; Ng SY
Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
[TBL] [Abstract][Full Text] [Related]
6. [iPS cell therapy for Parkinson's disease].
Takahashi J
Rinsho Ketsueki; 2016 Aug; 57(8):1080-6. PubMed ID: 27599427
[TBL] [Abstract][Full Text] [Related]
7. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.
Levy YS; Stroomza M; Melamed E; Offen D
J Mol Neurosci; 2004; 24(3):353-86. PubMed ID: 15655260
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
9. Preparing for first human trial of induced pluripotent stem cell-derived cells for Parkinson's disease: an interview with Jun Takahashi.
Takahashi J
Regen Med; 2019 Feb; 14(2):93-95. PubMed ID: 30644333
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.
Xu X; Huang J; Li J; Liu L; Han C; Shen Y; Zhang G; Jiang H; Lin Z; Xiong N; Wang T
Cell Prolif; 2016 Feb; 49(1):14-26. PubMed ID: 26748765
[TBL] [Abstract][Full Text] [Related]
11. How useful are stem cells in PD therapy?
Luo Y; Kuang SY; Hoffer B
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S171-5. PubMed ID: 20082984
[TBL] [Abstract][Full Text] [Related]
12. Human induced pluripotent stem cells in Parkinson's disease: A novel cell source of cell therapy and disease modeling.
Li W; Chen S; Li JY
Prog Neurobiol; 2015 Nov; 134():161-77. PubMed ID: 26408505
[TBL] [Abstract][Full Text] [Related]
13. Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease.
Grow DA; McCarrey JR; Navara CS
Stem Cell Res; 2016 Sep; 17(2):352-366. PubMed ID: 27622596
[TBL] [Abstract][Full Text] [Related]
14. Current Developments in Cell Replacement Therapy for Parkinson's Disease.
Guo X; Tang L; Tang X
Neuroscience; 2021 May; 463():370-382. PubMed ID: 33774124
[TBL] [Abstract][Full Text] [Related]
15. An Update on Human Stem Cell-Based Therapy in Parkinson's Disease.
González C; Bonilla S; Flores AI; Cano E; Liste I
Curr Stem Cell Res Ther; 2016; 11(7):561-8. PubMed ID: 26027681
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges.
Xiao B; Ng HH; Takahashi R; Tan EK
J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):697-702. PubMed ID: 26833176
[TBL] [Abstract][Full Text] [Related]
17. Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease.
Rodriguez-Pallares J; Rodriguez-Perez AI; Muñoz A; Parga JA; Toledo-Aral JJ; Labandeira-Garcia JL
Stem Cells Transl Med; 2016 Jun; 5(6):804-15. PubMed ID: 27075764
[TBL] [Abstract][Full Text] [Related]
18. Cell Therapy for Parkinson's Disease.
Morizane A; Takahashi J
Neurol Med Chir (Tokyo); 2016; 56(3):102-9. PubMed ID: 26912295
[TBL] [Abstract][Full Text] [Related]
19. Stem Cells for Modeling and Therapy of Parkinson's Disease.
Zhang Q; Chen W; Tan S; Lin T
Hum Gene Ther; 2017 Jan; 28(1):85-98. PubMed ID: 27762639
[TBL] [Abstract][Full Text] [Related]
20. Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson's Disease.
Henchcliffe C; Sarva H
CNS Drugs; 2020 Jun; 34(6):559-577. PubMed ID: 32472450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
